(VIANEWS) – ARMOUR Residential REIT (ARR), First Hawaiian (FHB), Eli Lilly and Company (LLY) are the highest payout ratio stocks on this list.

Here’s the data we’ve collected of stocks with a high payout ratio so far. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. ARMOUR Residential REIT (ARR)

53.33% Payout Ratio

ARMOUR Residential REIT, Inc. invests in residential mortgage backed securities in the United States.

Volume

Today’s last reported volume for ARMOUR Residential REIT is 1404040, 17.12% below its average volume of 1694250.

As stated by Morningstar, Inc., the next dividend payment is on Aug 12, 2021, the estimated forward annual dividend rate is 1.2 and the estimated forward annual dividend yield is 11.51%.

ARMOUR Residential REIT’s sales growth this year is anticipated to be negative 35.7% and 11.4% for next year.

ARMOUR Residential REIT’s sales growth for the next quarter is negative 6.3%. The company’s growth estimates for the ongoing quarter and the next is negative 28.6% and negative -18.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.49%.

ARMOUR Residential REIT’s Stock Yearly Top and Bottom Value

ARMOUR Residential REIT’s stock is valued at $10.90 at 02:23 EST, way under its 52-week high of $12.56 and way above its 52-week low of $8.90.

ARMOUR Residential REIT’s Moving Average

ARMOUR Residential REIT’s worth is higher than its 50-day moving average of $10.63 and under its 200-day moving average of $11.59.

2. First Hawaiian (FHB)

49.76% Payout Ratio

First Hawaiian, Inc. operates as a bank holding company for First Hawaiian Bank that provides a range of banking services to consumer and commercial customers in the United States.

Volume

Today’s last reported volume for First Hawaiian is 108372, 84.49% below its average volume of 698923.

As stated by Morningstar, Inc., the next dividend payment is on Aug 19, 2021, the estimated forward annual dividend rate is 1.04 and the estimated forward annual dividend yield is 3.88%.

First Hawaiian’s sales growth this year is expected to be negative 1.8% and 1.2% for next year.

Year-on-year quarterly revenue growth grew by 82.9%, now sitting on 735.53M for the twelve trailing months.

First Hawaiian’s sales growth is negative 0.1% for the present quarter and negative 3.6% for the next. The company’s growth estimates for the current quarter and the next is negative 4% and negative -6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.99%.

Volatility

First Hawaiian’s last day, week, and month’s current volatility was 1.32%, 0.55%, and 1.03%, respectively.

First Hawaiian’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.11% (day), 1.75% (last week), and 2.01% (last month), respectively.

First Hawaiian’s Stock Yearly Top and Bottom Value

First Hawaiian’s stock is valued at $27.10 at 02:23 EST, way below its 52-week high of $30.80 and way higher than its 52-week low of $14.15.

First Hawaiian’s Moving Average

First Hawaiian’s value is under its 50-day moving average of $27.49 and below its 200-day moving average of $28.02.

3. Eli Lilly and Company (LLY)

45.96% Payout Ratio

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide.

Volume

Today’s last reported volume for Eli Lilly and Company is 2656270, 2.55% below its average volume of 2725960.

As claimed by Morningstar, Inc., the next dividend payment is on May 12, 2021, the estimated forward annual dividend rate is 3.4 and the estimated forward annual dividend yield is 1.57%.

Eli Lilly and Company’s sales growth this year is anticipated to be 10.8% and 2.5% for next year.

Year-on-year quarterly revenue growth grew by 16.1%, now sitting on 25.49B for the twelve trailing months.

Eli Lilly and Company’s sales growth is 14.5% for the ongoing quarter and negative 4.8% for the next. The company’s growth estimates for the current quarter and the next is 27.9% and negative -21.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 118.34%.

Volatility

Eli Lilly and Company’s last day, week, and month’s current volatility was 0.02%, 0.75%, and 0.93%, respectively.

Eli Lilly and Company’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.64% (day), 1.71% (last week), and 1.96% (last month), respectively.

Eli Lilly and Company’s Stock Yearly Top and Bottom Value

Eli Lilly and Company’s stock is valued at $231.04 at 02:23 EST, way below its 52-week high of $275.87 and way above its 52-week low of $129.21.

Eli Lilly and Company’s Moving Average

Eli Lilly and Company’s value is way under its 50-day moving average of $257.58 and above its 200-day moving average of $218.63.

Previous days news about Eli Lilly and Company (LLY)

  • According to Business Insider on Thursday, 16 September, "The U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab 700 mg and etesevimab 1400 mg administered together to include post-exposure prophylaxis (PEP) in certain individuals for the prevention of SARS-CoV-2 infection, Eli Lilly and Company (NYSE: LLY) announced today. "
  • According to Benzinga on Thursday, 16 September, "Leveraging 30 years of experience in pharmacovigilance, Jean Paul worked for large pharmaceutical groups, including Eli Lilly and Company and GlaxoSmithKline, as well as biotech companies following his first position as Phase I physician at Fournier. "

4. Archer (ADM)

35.61% Payout Ratio

Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities, products, and ingredients in the United States and internationally.

Volume

Today’s last reported volume for Archer is 3055660, 29.46% above its average volume of 2360220.

According to Morningstar, Inc., the next dividend payment is on Aug 16, 2021, the estimated forward annual dividend rate is 1.48 and the estimated forward annual dividend yield is 2.47%.

Archer’s sales growth this year is anticipated to be 23% and 0.2% for next year.

Year-on-year quarterly revenue growth grew by 40.8%, now sitting on 74.92B for the twelve trailing months.

Archer’s sales growth is 6.4% for the present quarter and 10.4% for the next. The company’s growth estimates for the present quarter and the next is negative 1.1% and negative -1.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.32%.

Volatility

Archer’s last day, week, and month’s current volatility was 0.05%, 0.51%, and 0.94%, respectively.

Archer’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.11% (day), 1.31% (last week), and 1.54% (last month), respectively.

Archer’s Stock Yearly Top and Bottom Value

Archer’s stock is valued at $63.00 at 02:23 EST, under its 52-week high of $69.30 and way above its 52-week low of $44.58.

Archer’s Moving Average

Archer’s value is above its 50-day moving average of $60.14 and above its 200-day moving average of $61.05.

LEAVE A REPLY

Please enter your comment!
Please enter your name here